Cerenome PSTV
PSTV
$3.84 +0.07 (+1.86%)
At close: Aug 7, 2026 · 4:00 PM EDT

Cerenome (PSTV) Goodwill (2010 - 2026)

Plus Therapeutics (PSTV) posted quarterly Goodwill of $372000.0 for Q1 2026, little changed year-over-year from $372000.0 in Q1 2025, and little changed quarter-over-quarter from $372000.0 in Q4 2025.

Cerenome (PSTV) Goodwill (2010 - 2026) Analysis & Trends

Plus Therapeutics (PSTV) has reported Goodwill for 17 consecutive years, with $372000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill changed 0.0% year-over-year to $372000.0; the TTM figure through Mar 2026 stood at $372000.0 (changed 0.0% YoY), while the FY2025 annual figure was $372000.0, changed N/A from the prior year.
  • Goodwill steadied at $372000.0 in Q1 2026 per PSTV's latest filing, from $372000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $372000.0 in Q1 2022 and bottomed at $372000.0 in Q1 2022.
  • Historically, Goodwill has averaged $372000.0 across 5 years, with a median of $372000.0 in 2022.
  • On a YoY basis, Goodwill climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
  • Plus Therapeutics' Goodwill stood at $372000.0 in 2022, then changed by 0.0% to $372000.0 in 2023, then changed by 0.0% to $372000.0 in 2024, then changed by 0.0% to $372000.0 in 2025, then changed by 0.0% to $372000.0 in 2026.
  • Business Quant data shows PSTV's Goodwill at $372000.0 in Q1 2026, $372000.0 in Q4 2025, and $372000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Cerenome 28.07 Mn 19.48 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 372,000.00
Dec 31, 2025 372,000.00
Sep 30, 2025 372,000.00
Jun 30, 2025 372,000.00
Mar 31, 2025 372,000.00
Sep 30, 2024 372,000.00
Jun 30, 2024 372,000.00
Mar 31, 2024 372,000.00
Dec 31, 2023 372,000.00
Sep 30, 2023 372,000.00
Jun 30, 2023 372,000.00
Mar 31, 2023 372,000.00
Dec 31, 2022 372,000.00
Sep 30, 2022 372,000.00
Jun 30, 2022 372,000.00
Mar 31, 2022 372,000.00
Dec 31, 2021 372,000.00
Sep 30, 2021 372,000.00
Jun 30, 2021 372,000.00
Mar 31, 2021 372,000.00